Click for best price
Nucleic Acid Based Gene Therapy Market Size, Share 2023
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Based Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Based Gene Therapy. This report contains market size and forecasts of Nucleic Acid Based Gene Therapy in global, including the following market information:
Global Nucleic Acid Based Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nucleic Acid Based Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Anti-Sence and Anti-Gene Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nucleic Acid Based Gene Therapy include Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics and Deep Genomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nucleic Acid Based Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid Based Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others
Global Nucleic Acid Based Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Academic and Research Institutes
Others
Global Nucleic Acid Based Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nucleic Acid Based Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nucleic Acid Based Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nucleic Acid Based Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nucleic Acid Based Gene Therapy, market overview.
Chapter 2: Global Nucleic Acid Based Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Nucleic Acid Based Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nucleic Acid Based Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nucleic Acid Based Gene Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Based Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Based Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Based Gene Therapy Overall Market Size
2.1 Global Nucleic Acid Based Gene Therapy Market Size: 2022 VS 2032
2.2 Global Nucleic Acid Based Gene Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nucleic Acid Based Gene Therapy Players in Global Market
3.2 Top Global Nucleic Acid Based Gene Therapy Companies Ranked by Revenue
3.3 Global Nucleic Acid Based Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid Based Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nucleic Acid Based Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Nucleic Acid Based Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nucleic Acid Based Gene Therapy Market Size Markets, 2022 & 2032
4.1.2 Anti-Sence and Anti-Gene
4.1.3 Short Inhibitory Sequences
4.1.4 Gene Transfer Therapy
4.1.5 Nucleoside Analogs
4.1.6 Ribozymes
4.1.7 Aptamers
4.1.8 Others
4.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
4.2.3 By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nucleic Acid Based Gene Therapy Market Size, 2022 & 2032
5.1.2 Hospitals and Clinics
5.1.3 Academic and Research Institutes
5.1.4 Others
5.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
5.2.3 By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nucleic Acid Based Gene Therapy Market Size, 2022 & 2032
6.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Nucleic Acid Based Gene Therapy Revenue, 2024-2032
6.2.3 By Region - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.3.2 US Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.3.3 Canada Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.3.4 Mexico Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.4.2 Germany Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.3 France Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.4 U.K. Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.5 Italy Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.6 Russia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.4.8 Benelux Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.5.2 China Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.3 Japan Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.4 South Korea Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.5.6 India Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.6.2 Brazil Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.6.3 Argentina Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, 2018-2032
6.7.2 Turkey Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.3 Israel Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Nucleic Acid Based Gene Therapy Market Size, 2018-2032
6.7.5 UAE Nucleic Acid Based Gene Therapy Market Size, 2018-2032
7 Nucleic Acid Based Gene Therapy Companies Profiles
7.1 Wave Life Sciences
7.1.1 Wave Life Sciences Company Summary
7.1.2 Wave Life Sciences Business Overview
7.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Major Product Offerings
7.1.4 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Wave Life Sciences Key News & Latest Developments
7.2 Imugene
7.2.1 Imugene Company Summary
7.2.2 Imugene Business Overview
7.2.3 Imugene Nucleic Acid Based Gene Therapy Major Product Offerings
7.2.4 Imugene Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Imugene Key News & Latest Developments
7.3 Sarepta Therapeutics
7.3.1 Sarepta Therapeutics Company Summary
7.3.2 Sarepta Therapeutics Business Overview
7.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
7.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Sarepta Therapeutics Key News & Latest Developments
7.4 Alnylam Pharmaceuticals
7.4.1 Alnylam Pharmaceuticals Company Summary
7.4.2 Alnylam Pharmaceuticals Business Overview
7.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
7.4.4 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.5 Ionis Pharmaceuticals
7.5.1 Ionis Pharmaceuticals Company Summary
7.5.2 Ionis Pharmaceuticals Business Overview
7.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Major Product Offerings
7.5.4 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Ionis Pharmaceuticals Key News & Latest Developments
7.6 Moderna
7.6.1 Moderna Company Summary
7.6.2 Moderna Business Overview
7.6.3 Moderna Nucleic Acid Based Gene Therapy Major Product Offerings
7.6.4 Moderna Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Moderna Key News & Latest Developments
7.7 BioNTech
7.7.1 BioNTech Company Summary
7.7.2 BioNTech Business Overview
7.7.3 BioNTech Nucleic Acid Based Gene Therapy Major Product Offerings
7.7.4 BioNTech Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 BioNTech Key News & Latest Developments
7.8 Nutcracker Therapeutics
7.8.1 Nutcracker Therapeutics Company Summary
7.8.2 Nutcracker Therapeutics Business Overview
7.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Major Product Offerings
7.8.4 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Nutcracker Therapeutics Key News & Latest Developments
7.9 Deep Genomics
7.9.1 Deep Genomics Company Summary
7.9.2 Deep Genomics Business Overview
7.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Major Product Offerings
7.9.4 Deep Genomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Deep Genomics Key News & Latest Developments
7.10 Sirnaomics
7.10.1 Sirnaomics Company Summary
7.10.2 Sirnaomics Business Overview
7.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Major Product Offerings
7.10.4 Sirnaomics Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Sirnaomics Key News & Latest Developments
7.11 Laronde
7.11.1 Laronde Company Summary
7.11.2 Laronde Business Overview
7.11.3 Laronde Nucleic Acid Based Gene Therapy Major Product Offerings
7.11.4 Laronde Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 Laronde Key News & Latest Developments
7.12 Abogen Biosciences
7.12.1 Abogen Biosciences Company Summary
7.12.2 Abogen Biosciences Business Overview
7.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Major Product Offerings
7.12.4 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Abogen Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nucleic Acid Based Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid Based Gene Therapy Market Drivers in Global Market
Table 3. Nucleic Acid Based Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid Based Gene Therapy in Global Market
Table 5. Top Nucleic Acid Based Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nucleic Acid Based Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nucleic Acid Based Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nucleic Acid Based Gene Therapy Product Type
Table 9. List of Global Tier 1 Nucleic Acid Based Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nucleic Acid Based Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nucleic Acid Based Gene Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Nucleic Acid Based Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nucleic Acid Based Gene Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Wave Life Sciences Company Summary
Table 31. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offerings
Table 32. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Wave Life Sciences Key News & Latest Developments
Table 34. Imugene Company Summary
Table 35. Imugene Nucleic Acid Based Gene Therapy Product Offerings
Table 36. Imugene Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Imugene Key News & Latest Developments
Table 38. Sarepta Therapeutics Company Summary
Table 39. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offerings
Table 40. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Sarepta Therapeutics Key News & Latest Developments
Table 42. Alnylam Pharmaceuticals Company Summary
Table 43. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offerings
Table 44. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Alnylam Pharmaceuticals Key News & Latest Developments
Table 46. Ionis Pharmaceuticals Company Summary
Table 47. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offerings
Table 48. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Ionis Pharmaceuticals Key News & Latest Developments
Table 50. Moderna Company Summary
Table 51. Moderna Nucleic Acid Based Gene Therapy Product Offerings
Table 52. Moderna Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Moderna Key News & Latest Developments
Table 54. BioNTech Company Summary
Table 55. BioNTech Nucleic Acid Based Gene Therapy Product Offerings
Table 56. BioNTech Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. BioNTech Key News & Latest Developments
Table 58. Nutcracker Therapeutics Company Summary
Table 59. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offerings
Table 60. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Nutcracker Therapeutics Key News & Latest Developments
Table 62. Deep Genomics Company Summary
Table 63. Deep Genomics Nucleic Acid Based Gene Therapy Product Offerings
Table 64. Deep Genomics Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Deep Genomics Key News & Latest Developments
Table 66. Sirnaomics Company Summary
Table 67. Sirnaomics Nucleic Acid Based Gene Therapy Product Offerings
Table 68. Sirnaomics Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Sirnaomics Key News & Latest Developments
Table 70. Laronde Company Summary
Table 71. Laronde Nucleic Acid Based Gene Therapy Product Offerings
Table 72. Laronde Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Laronde Key News & Latest Developments
Table 74. Abogen Biosciences Company Summary
Table 75. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offerings
Table 76. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Abogen Biosciences Key News & Latest Developments
List of Figures
Figure 1. Nucleic Acid Based Gene Therapy Segment by Type in 2022
Figure 2. Nucleic Acid Based Gene Therapy Segment by Application in 2022
Figure 3. Global Nucleic Acid Based Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nucleic Acid Based Gene Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2022
Figure 8. By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 16. US Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 28. China Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Nucleic Acid Based Gene Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Nucleic Acid Based Gene Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Imugene Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Moderna Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BioNTech Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Deep Genomics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sirnaomics Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Laronde Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
